We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Brain Tumors Grow by Tapping Preexisting Blood Vessels for Nutrients

By LabMedica International staff writers
Posted on 24 Aug 2014
Findings from a new study on how tumors grow and spread in the brain may cause cancer researchers to rethink treatment options based on drugs that block angiogenesis.

According to the angiogenesis theory, tumors that are more than one cubic millimeter in size need to attract or grow their own blood vessels to survive. More...
This theory led to clinical trials with anti-angiogenesis drugs such as bevacizumab and DC101. However, such clinical trials have failed to produce evidence of reduced tumor growth or increased patient survival.

Investigators at the University of Michigan (Ann Arbor, USA) examined this phenomenon in rodents and human cancer patients and by advanced computer modeling.

They reported in the July 2014 issue of the journal Neoplasia that implanted rodent and human brain cancer cells commonly invaded and proliferated within the brain perivascular space. This form of brain tumor growth and invasion was also shown to characterize de novo generated endogenous mouse brain tumors, biopsies of primary human glioblastoma, and peripheral cancer metastasis to the human brain.

Perivascularly invading brain tumors became vascularized by normal brain microvessels when individual glioma cells used perivascular space as a conduit for tumor invasion. Since the cancer cells were obtaining blood from already existing vascular tissues, their growth and spread were not impeded by treatment with antiangiogenic agents.

The experimental findings showing that tumor perivascular spreading was independent of growth of new blood vessels had been predicted by computational modeling. The investigators tested this prediction experimentally by blocking angiogenic signaling using antibodies targeting the VEGF-A (vascular endothelial growth factor) signaling axis. VEGF-A inhibitors failed to block progressive tumor growth or extend median survival in multiple brain tumor models.

"The key question has been to determine how tumor-generating cells grow to form the macroscopic tumor mass that eventually kills the patients," said senior author Dr. Pedro Lowenstein, professor of neurosurgery and cell and developmental biology at the University of Michigan. "We have shown that because of the very high density of endogenous vessels in the brain and central nervous system, the cells grow along those preexisting vessels and eventually divide to fill the space between them, where the distance between any two vessels is very small. This iterative growth along vessels and into the space between means the tumor does not grow like a balloon requiring new vessels to grow into its expanding mass to rescue it, but rather as an accumulation of local small masses which then coalesce into a large tumor."

Related Links:

University of Michigan



New
Gold Member
Automatic Hematology Analyzer
DH-800 Series
Portable Electronic Pipette
Mini 96
New
Gold Member
Automated MALDI-TOF MS System
EXS 3000
New
Gold Member
Collection and Transport System
PurSafe Plus®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more

Immunology

view channel
Image: The CloneSeq-SV approach can allow researchers to study how cells within high-grade serous ovarian cancer change over time (Photo courtesy of MSK)

Blood Test Tracks Treatment Resistance in High-Grade Serous Ovarian Cancer

High-grade serous ovarian cancer (HGSOC) is often diagnosed at an advanced stage because it spreads microscopically throughout the abdomen, and although initial surgery and chemotherapy can work, most... Read more

Industry

view channel
Image: The collaboration aims to improve access to Hb variant testing with the Gazelle POC diagnostic platform (Photo courtesy of Hemex Health)

Terumo BCT and Hemex Health Collaborate to Improve Access to Testing for Hemoglobin Disorders

Millions of people worldwide living with sickle cell disease and other hemoglobin disorders experience delayed diagnosis and limited access to effective care, particularly in regions where testing is scarce.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.